Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Estrogen replacement therapy: myth or reality?]

C Jamin

    Contraception, Fertilite, Sexualite (1992)
    |January 10, 1998
    PubMed
    Summary
    This summary is machine-generated.

    Women lose cardiovascular protection after menopause due to hormonal changes. Insulin resistance, not just cholesterol, is key, and estrogen therapy may help mitigate risks.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Within patient horizontal gene transfer dynamics of a bla<sub>NDM-7</sub> plasmid among four different bacterial species.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2025
    Same author

    [The MASK lift].

    Annales de chirurgie plastique et esthetique·2024
    Same author

    Role of the environment in transmission of Gram-negative bacteria in two consecutive outbreaks in a haematology-oncology department.

    Infection prevention in practice·2022
    Same author

    Epidemiological, clinical, and echocardiographic features, and outcome of dogs with Ebstein's anomaly: 32 cases (2002-2016).

    Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2020
    Same author

    Assessment of bovine tuberculosis surveillance effectiveness in French wildlife: An operational approach.

    Preventive veterinary medicine·2020
    Same author

    [Is AMH a fertility marker?]

    Gynecologie, obstetrique, fertilite & senologie·2019
    Same journal

    [Inflammatory and/or locally advanced breast cancers. Difficulty evaluating the response to initial chemotherapy].

    Contraception, fertilite, sexualite (1992)·2000
    Same journal

    [Proximal tubal unblocking by selective salpingography, apropos of 8 cases].

    Contraception, fertilite, sexualite (1992)·2000
    Same journal

    [Anatomoclinical correlations of endometriosis].

    Contraception, fertilite, sexualite (1992)·2000
    Same journal

    [Effects of raloxifene on bone loss and fracture risk in the menopausal woman].

    Contraception, fertilite, sexualite (1992)·2000
    Same journal

    [Cytological screening of uterine cervical cancer by samples in liquid medium (CytoRich). Preliminary study of a series of 111 292 patients].

    Contraception, fertilite, sexualite (1992)·2000
    Same journal

    [Diabetes before pregnancy, apropos of 143 cases].

    Contraception, fertilite, sexualite (1992)·2000
    See all related articles

    Area of Science:

    • Cardiology
    • Endocrinology
    • Epidemiology

    Context:

    • Cardiovascular disease (CVD) risk increases in women post-menopause.
    • Estrogen decline during menopause is implicated in this increased risk.
    • Understanding the mechanisms behind this shift is crucial for prevention.

    Purpose:

    • To explore the epidemiological evidence linking menopause to cardiovascular disease.
    • To investigate the role of hormonal changes and metabolic factors in post-menopausal CVD.
    • To evaluate the impact of hormone replacement therapy (HRT) on cardiovascular risk.

    Summary:

    • Post-menopausal women experience a loss of cardiovascular protection, with hormonal shifts playing a significant role.
    • Insulin resistance markers like hypertriglyceridemia and hypoHDLemia are more critical than hypercholesterolemia in this demographic.

    Related Experiment Videos

  • Estrogen therapy shows potential in reducing coronary risk, while progestins have no significant effect.

    • Impact:

    • Highlights the importance of metabolic factors beyond cholesterol in post-menopausal cardiovascular health.
    • Suggests estrogen therapy as a potential preventive strategy, with careful consideration of administration methods and patient risk factors.
    • Underscores the need for further research into the specific mechanisms and optimal application of HRT for cardiovascular prevention.